According to the WHO, the main markers differentiating APL from other AML are HLA-DR, CD34, the homogeneous and strong expression of CD33, negative or weakly expressed CD15, and the expression of CD64 that is common in APL. This evidence concerns the gene CD33 and acute myeloid leukemia.